Table 1.
Demographic and clinical characteristics, physical activity and sedentary time of the participants.
| N | Value | SD | |
|---|---|---|---|
| Age (years), mean | 62 | 36.3 | 13.7 |
| Gender (women, %) | 62 | 27 (43.5) | – |
| Duration illness (years) | 61 | 14.9 | 12.2 |
| Smokers (%) | 62 | 40 (64.5) | – |
| Body mass index (kg*m−2) | 62 | 29.2 | 5.7 |
| PANSS positive subscale* (score range 7–42) | 62 | 15.2 | 5.1 |
| PANSS negative subscale* (score range 7–42) | 61 | 17.9 | 7.0 |
| PANSS total score* (score range 30–210) | 61 | 65.3 | 17.5 |
| Antipsychotic medication DDD** | 62 | 1.7 | 0.9 |
| Light intensity Physical activity (min/day−1) | 62 | 216 | 92.4 |
| Moderate/vigorous physical activity (min/day−1) | 62 | 28.7 | 31.0 |
| Steps/day (steps*day−1) | 62 | 5685.0 | 3641.0 |
| Sedentary time (h*day−1) | 62 | 8.6 | 1.6 |
| VO2peak (mL*kg−1*min−1), all participants | 62 | 30.2 | 11.6 |
| VO2peak (mL*kg−1*min−1), participants fulfilling maximal effort criteria*** | 52 | 31.5 | 11.8 |
| VO2peak (mL*kg−1*min−1), participants not fulfilling maximal effort criteria**** | 10 | 33.9 | 7.7 |
Data presented in % or mean.
*
PANSS, Positive and Negative Syndrome Scale;
**
DDD, defined daily dose, dose equivalence estimate based on total intake of antipsychotics per day;
***
Respiratory exchange ratio≥ 1.00.
****
Respiratory exchange ratio < 1.00.